FRIDAY, Jan. 4, 2022 (HealthDay News) — Medicare will soon provide up to eight free COVID rapid tests a month to seniors enrolled in the government health insurance program, the Biden administration announced Thursday. The new policy for the over-the-counter tests will take effect in early spring. The at-home testsContinue Reading
MONDAY, Jan. 31, 2022 (HealthDay News) — California lawmakers must vote by Monday on whether to keep a bill to create a universal health care system moving forward. Monday, Jan. 31, is the last chance for California Democrats in the Assembly to keep the bill alive this year. That billContinue Reading
FRIDAY, Jan. 21, 2022 (HealthDay News) — Your heart is in an incredibly vulnerable state if you’ve suffered a heart attack or are fighting heart failure, and cardiac rehabilitation could be an important part of your recovery. Unfortunately, not enough older folks appear to be taking advantage of this life-savingContinue Reading
WEDNESDAY, Jan. 19, 2022 (HealthDay News) — Big surprise bills for any colonoscopy done after a positive result from a stool-based screening test will be prevented under new federal rules, a group of U.S. medical organizations say. On Jan. 10, the Biden administration issued guidance requiring private insurers to coverContinue Reading
TUESDAY, Jan. 18, 2022 (HealthDay News) — Home COVID tests are now available at no cost to most Americans, as part of the Biden administration’s effort to increase testing around the United States. Folks can buy home tests online or in stores and be fully reimbursed by their private insurance,Continue Reading
MONDAY, Jan. 17, 2022 (HealthDay News) — U.S. insurers are paying millions of dollars a year to cover the cost of ivermectin for COVID-19 patients despite a lack of proof the anti-parasitic drug is effective against the virus, a new study finds. Both the U.S. Food and Drug Administration andContinue Reading
WEDNESDAY, Jan. 12, 2022 (HealthDay News) — The chance of someone who is covered by Medicaid surviving cancer may depend in part on where they live, a new analysis finds. In states that had lower Medicaid income eligibility limits, cancer survival rates were worse for cancers both in early andContinue Reading
TUESDAY, Jan. 11, 2022 (HealthDay News) — It’s a move that could severely limit the number of people taking the controversial new Alzheimer’s drug Aduhelm: Medicare on Tuesday proposed to only cover the cost of the pricey medication for people enrolled in approved clinical trials. A final decision on coverageContinue Reading
MONDAY, Jan. 10, 2022 (HealthDay News) — Medicare has been told to reassess a significant premium increase it had announced that largely stemmed from the expensive new Alzheimer’s drug Aduhelm. U.S. Health and Human Services Secretary Xavier Becerra’s directive, which was announced on Monday, comes shortly after Aduhelm maker BiogenContinue Reading
FRIDAY, Jan. 7, 2022 (HealthDay News) — Following a months-long and unprecedented review, Medicare officials expect to announce within the next couple of weeks whether the program will cover the controversial Alzheimer’s drug Aduhelm. The drug’s benefits are in question and its annual price tag tops $28,000. The U.S. CentersContinue Reading